ELK GROVE VILLAGE, Ill., Nov. 25, 2024 /PRNewswire/ -- Orsini is now distributing BridgeBio's ATTRUBY™ (acoramidis), an orally administered treatment for cardiomyopathy of wild-type or variant transthyretin-mediated amyloidosis (ATTR-CM). ATTRUBY is a near-complete (≥90%) stabilizer of...
Orsini Chosen by BridgeBio as a Specialty Pharmacy Provider for ATTRUBY™ (acoramidis), for the Treatment of Cardiomyopathy of Transthyretin-Mediated Amyloidosis
Seaking AlphaSeeking Alpha / Seaking Alpha 2 hours ago 1 Views
Comments